Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53 -Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes
Mishra, Asmita, Tamari, Roni, DeZern, Amy E, Byrne, Michael T, Gooptu, Mahasweta, Chen, Yi-Bin, Deeg, H Joachim, Sallman, David, Gallacher, Phillip, Wennborg, Anders, Hickman, Denice K, Attar, Eyal C, Fernandez, Hugo F
Published in Journal of clinical oncology (01.12.2022)
Published in Journal of clinical oncology (01.12.2022)
Get full text
Journal Article
Machine learning reveals chronic graft- versus -host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies
Gandelman, Jocelyn S, Byrne, Michael T, Mistry, Akshitkumar M, Polikowsky, Hannah G, Diggins, Kirsten E, Chen, Heidi, Lee, Stephanie J, Arora, Mukta, Cutler, Corey, Flowers, Mary, Pidala, Joseph, Irish, Jonathan M, Jagasia, Madan H
Published in Haematologica (Roma) (01.01.2019)
Published in Haematologica (Roma) (01.01.2019)
Get full text
Journal Article
Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience
Dholaria, Bhagirathbhai, Mehraban, Nasima, Baer, Brittney, Long, Nancy, Jayani, Reena V., Byrne, Michael T., Kassim, Adetola A., Engelhardt, Brian G., Savani, Bipin N., Oluwole, Olalekan O.
Published in British journal of haematology (01.09.2022)
Published in British journal of haematology (01.09.2022)
Get full text
Journal Article
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia
Gatwood, Katie S, Culos, Kathryn A, Binari, Laura A, Engelhardt, Brian G, Kassim, Adetola, Byrne, Michael T, Goodman, Stacey A, Chinratanalab, Wichai, Sengsayadeth, Salyka M, Greer, John P, Jagasia, Madan, Savani, Bipin N
Published in Bone marrow transplantation (Basingstoke) (01.06.2018)
Published in Bone marrow transplantation (Basingstoke) (01.06.2018)
Get full text
Journal Article
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial
Roboz, Gail J., Sanz, Guillermo, Griffiths, Elizabeth A., Yee, Karen, Kantarjian, Hagop, Récher, Christian, Byrne, Michael T., Patkowska, Elżbieta, Kim, Hee-Je, Thomas, Xavier, Moors, Ine, Stock, Wendy, Illés, Árpád, Fenaux, Pierre, Miyazaki, Yasushi, Yamauchi, Takahiro, O'Connell, Casey L., Hao, Yong, Keer, Harold N., Azab, Mohammad, Döhner, Hartmut
Published in Blood advances (23.04.2024)
Published in Blood advances (23.04.2024)
Get full text
Journal Article
Distinguishing ASH clinical practice guidelines from other forms of ASH clinical advice
Cuker, Adam, Kunkle, Robert, Bercovitz, Rachel S., Byrne, Michael, Djulbegovic, Benjamin, Haberichter, Sandra L., Holter-Chakrabarty, Jennifer, Lottenberg, Richard, Pai, Menaka, Rezende, Suely M., Seftel, Matthew D., Silverstein, Roy L., Terrell, Deirdra R., Cheung, Matthew C.
Published in Blood advances (11.06.2024)
Published in Blood advances (11.06.2024)
Get full text
Journal Article
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma
Merryman, Reid W., Redd, Robert A., Nishihori, Taiga, Chavez, Julio, Nieto, Yago, Darrah, Justin M., Rao, Uttam, Byrne, Michael T., Bond, David A., Maddocks, Kami J., Spinner, Michael A., Advani, Ranjana H., Ballard, Hatcher J., Svoboda, Jakub, Singh, Anurag K., McGuirk, Joseph P., Modi, Dipenkumar, Ramchandren, Radhakrishnan, Romancik, Jason, Cohen, Jonathon B., Frigault, Matthew J., Chen, Yi-Bin, Serritella, Anthony V., Kline, Justine, Ansell, Stephen, Nathan, Sunita, Rahimian, Maryam, Joyce, Robin M., Shah, Mansi, David, Kevin A., Park, Steven, Beaven, Anne W., Habib, Alma, Bachanova, Veronika, Nakhoda, Shazia, Khan, Nadia, Lynch, Ryan C., Smith, Stephen D., Ho, Vincent T., LaCasce, Ann, Armand, Philippe, Herrera, Alex F.
Published in Blood advances (23.03.2021)
Published in Blood advances (23.03.2021)
Get full text
Journal Article
What is the indication for sorafenib in hepatocellular carcinoma? A clinical challenge
Kim, Richard, Byrne, Michael T, Tan, Ann, Aucejo, Federico
Published in Oncology (Williston Park, N.Y.) (01.03.2011)
Get full text
Published in Oncology (Williston Park, N.Y.) (01.03.2011)
Journal Article
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling
Johnpulle, Romany A.N., Paczesny, Sophie, Jung, Dae Kwang, Daguindau, Etienne, Jagasia, Madan H., Savani, Bipin N., Chinratanalab, Wichai, Cornell, Robert F., Goodman, Stacey, Greer, John P., Kassim, Adetola A., Sengsayadeth, Salyka, Byrne, Michael T., Engelhardt, Brian G.
Published in Biology of blood and marrow transplantation (01.03.2017)
Published in Biology of blood and marrow transplantation (01.03.2017)
Get full text
Journal Article
Postsplenectomy thromboembolic disease in congenital sideroblastic anaemia
Byrne, Michael T, Bergman, Anke K, Ruiz, Angela I, Silver, Bernard J, Maciejewski, Jaroslaw P, Tiu, Ramon V
Published in BMJ case reports (17.09.2010)
Published in BMJ case reports (17.09.2010)
Get full text
Journal Article
Metabolic Complications Precede Alloreactivity and are Characterized by Changes in ST2 Signaling
Johnpulle, Romany A.N, Paczesny, Sophie, Jung, Dae Kwang, Daguindau, Etienne, Jagasia, Madan H, Savani, Bipin N, Chinratanalab, Wichai, Cornell, Robert F, Goodman, Stacey, Greer, John P, Kassim, Adetola A, Sengsayadeth, Salyka, Byrne, Michael T, Engelhardt, Brian G
Published in Biology of blood and marrow transplantation (21.12.2016)
Published in Biology of blood and marrow transplantation (21.12.2016)
Get full text
Journal Article
Phase II Trial of Eprenetapopt (APR-246) in Combination with Azacitidine (AZA) As Maintenance Therapy for TP53 Mutated AML or MDS Following Allogeneic Stem Cell Transplantation (SCT)
Mishra, Asmita, Tamari, Roni, DeZern, Amy E., Byrne, Michael T., Gooptu, Mahasweta, Chen, Yi-Bin, Deeg, H. Joachim, Gallacher, Phillip, Wennborg, Anders, Kaylor Hickman, Denice, Attar, Eyal C., Fernandez, Hugo F.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
A Phase II Study of Ruxolitinib Pre-, during- and Post-Hematopoietic Celltransplantation for Patients with Primary or Secondary Myelofibrosis
Hobbs, Gabriela, Kim, Haesook T., Bottoms, AJ S., Byrne, Michael T., Schroeder, Mark A., Tamari, Roni, Wall, Sarah A, Defilipp, Zachariah, El-Jawahri, Areej, McAfee, Steven, Chen, Yi-Bin
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine: A Phase 1 / 2 Study in Patients with Myelodysplastic Syndrome (ASPEN-02)
Garcia-Manero, Guillermo, Erba, Harry P., Sanikommu, Srinivasa R., Altman, Jessica K., Sayar, Hamid, Scott, Bart L., Fong, Abraham P., Guan, Shanhong, Jin, Feng, Forgie, Alison J., Pons, Jaume, Randolph, Sophia S., Byrne, Michael T.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Reduction in Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Patel, Ameet, Wilkerson, Karina L, Culos, Kathryn A., Green, Jennifer, Byrne, Michael T., Sengsayadeth, Salyka M., Dholaria, Bhagirathbhai, Savani, Bipin N., Goodman, Stacey Ann, Chinratanalab, Wichai, Jayani, Reena, Gatwood, Katie S., Engelhardt, Brian G., Kassim, Adetola A.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations
Rao, Uttam K., Chen, Heidi, Gatwood, Katie S., Byrne, Michael T., Sengsayadeth, Salyka M., Goodman, Stacey A., Dholaria, Bhagirathbhai, Kassim, Adetola A., Savani, Bipin N., Chinratanalab, Wichai, Culos, Kathryn A., Savona, Michael R., Engelhardt, Brian G.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 302 Patients with Relapsed or Refractory (r/r) Acute Myeloid Leukemia after Intensive Chemotherapy (ASTRAL-2 Study)
Roboz, Gail J., Sanz, Guillermo, Griffiths, Elizabeth A., Yee, Karen, Kantarjian, Hagop, Recher, Christian, Byrne, Michael T., Patkowska, Elzbieta, Kim, Hee-Je, Thomas, Xavier, Moors, Ine, Stock, Wendy, Illes, Arpad, Fenaux, Pierre, Miyazaki, Yasushi, Yamauchi, Takahiro, O'Connell, Casey L., Hao, Yong, Keer, Harold N., Azab, Mohammad, Dohner, Hartmut
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article